What were CHUGAI PHARMACEUTICAL CO.,LTD.'s latest financial results?

CHUGAI PHARMACEUTICAL CO.,LTD. (4519.T) reported its latest results in an earnings disclosure filed with the Tokyo Stock Exchange. The full English translation is in the article above.

Where can I read CHUGAI PHARMACEUTICAL CO.,LTD.'s earnings disclosure in English?

Pulse News Wire provides real-time English translations of CHUGAI PHARMACEUTICAL CO.,LTD.'s TDNet filings, including this earnings report.

How quickly are CHUGAI PHARMACEUTICAL CO.,LTD.'s TSE filings translated into English?

Pulse News Wire translates Tokyo Stock Exchange disclosures typically within 5 minutes of filing, covering all 4,436 listed companies including CHUGAI PHARMACEUTICAL CO.,LTD..

| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Roche Reports FY25 Earnings; Holds 14.89% of Chugai Shares

Source disclosure: January 29, 2026 CHUGAI PHARMACEUTICAL CO.,LTD. [4519.T] TOKYO, Jan 29 (Pulse News Wire) – Roche Holding AG (CEO: Thomas Schinecker) reported its fiscal year 2025 earnings today. As of December 31, 2025, Roche Holding AG holds 14.89% of Chugai Pharmaceutical Co., Ltd.'s outstanding shares, representing a voting rights ratio of 14.89%. Chugai Pharmaceutical's representative, CEO Osamu Okada, stated that the earnings data includes Chugai’s performance from January 1

Source disclosure: January 29, 2026

CHUGAI PHARMACEUTICAL CO.,LTD. [4519.T]

TOKYO, Jan 29 (Pulse News Wire) – Roche Holding AG (CEO: Thomas Schinecker) reported its fiscal year 2025 earnings today. As of December 31, 2025, Roche Holding AG holds 14.89% of Chugai Pharmaceutical Co., Ltd.'s outstanding shares, representing a voting rights ratio of 14.89%.

Chugai Pharmaceutical's representative, CEO Osamu Okada, stated that the earnings data includes Chugai’s performance from January 1, 2025, to December 31, 2025.

AI-translated content. 🟢 Confidence: High See terms • Original filing

💬 Help us improve translation quality

Notice any errors in this article? Let us know with one click.

🎁 Report 3+ errors with your email and get a free month of premium access

Roche Reports FY25 Earnings; Holds 14.89% of Chugai Shares

Related Disclosures